Navigation Links
LCA-Vision Announces Consent Solicitation Deadline; Urges Stockholders to Return Gold Consent Revocation Card
Date:2/11/2009

CINCINNATI, Feb. 11 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV) today announced that it has received an executed written consent from Craig Joffe dated February 9, 2009. Based on the date of this consent, the expiration date of the consent solicitation will be April 9, 2009. The Company will issue another press release if it receives an earlier dated executed written consent.

LCA-Vision filed its Definitive Consent Revocation Statement ("Consent Revocation Statement") with the Securities and Exchange Commission on Monday, February 9, 2009, and copies of the Consent Revocation Statement with a GOLD Consent Revocation Card were mailed to stockholders beginning February 10, 2009. The Consent Revocation Statement can be obtained immediately from the SEC's website at the following link:

http://idea.sec.gov/Archives/edgar/data/1003130/000114420409006021/v139094_def

c14a.htm (due to length of url, please copy and paste into browser)

or from the Investor Relations section of the Company's website at www.lasikplus.com and www.lca-vision.com. Copies of the Consent Revocation Statement and consent revocation card may also be obtained from Georgeson Inc.

The Board of Directors of LCA-Vision has determined that the consent solicitation of the Joffe Group, proposing, among other things, to remove, without cause the directors that you elected at the 2008 annual meeting of stockholders, and replace them with a slate of nominees selected by the Joffe Group, is not in the best interests of LCA-Vision or its stockholders, and urges LCA-Vision stockholders to reject the Joffe Group's proposals.

Stockholders should not sign the Joffe Group's White consent card. If you have previously signed a White consent card, you may revoke that consent. The Board of Directors is mailing to LCA-Vision stockholders a GOLD consent revocation card that they should immediately sign, date and mail back. Stockholders may support their current board and management by signing, dating and mailing the GOLD consent revocation card as soon as they receive it.

Additional Information:

Georgeson Inc. has been retained by LCA-Vision as consent revocation solicitation agent. Stockholders with questions are encouraged to call them toll-free 1-800-457-0109. Copies of the Company's Consent Revocation Statement and any other documents filed by LCA-Vision with the SEC in connection with the consent solicitation can be obtained free of charge from the SEC's website at www.sec.gov, from the Company's website at www.lasikplus.com and www.lca-vision.com., or from Georgeson.

About LCA-Vision Inc./LasikPlus(R)

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus(R) brand, operates 75 LasikPlus(R) fixed-site laser vision correction centers in 32 states and 57 markets in the United States and a joint venture in Canada. Additional company information is available at www.lca-vision.com and www.lasikplus.com.

    Earning Trust Every Moment.
                                  Transforming Lives Every Day.


    For Additional Information

    Company Contact:                    Investor Relations Contact:
    Barb Kise                           Jody Cain
    LCA-Vision Inc.                     Lippert/Heilshorn & Associates
    513-792-9292                        310-691-7100

'/>"/>
SOURCE LCA-Vision Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results
2. LCA-Visions National Lasik Network Named as U.S. Provider for National Vision Administrators
3. The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders
4. LCA-Vision to Hold Corporate Update Conference Call and Q&A Session on February 6
5. LCA-Vision to Announce Fourth Quarter and Full Year 2008 Financial Results on Tuesday, February 10, 2009
6. The LCA-Vision Full Value Committee Files Preliminary Consent Solicitation Statement to Reconstitute the Board of Directors of LCA-Vision Inc.
7. LCA-Vision Urges Stockholders to Take No Action Regarding the Joffe Groups Threatened Consent Solicitation
8. LCA-Visions Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders
9. LCA-Vision Board of Directors Responds to Recent Letters from Stockholder Group
10. LCA-Visions Former Executive Management Urge Board of Directors to Immediately Call Special Shareholder Meeting to Approve Poison Pill
11. 11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
(Date:6/24/2016)... ... 2016 , ... Today, MTI-GlobalStem, a provider of optimized transfection ... to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing System ... is a complete system for culturing and transfecting human pluripotent stem cells for ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  Experian Health, the healthcare industry ... patient payment and care experience, today announced ... and services that will enhance the breadth ... These award-winning solutions will enable healthcare professionals ... in an ever-changing environment and redefine front-office ...
(Date:6/23/2016)... 2016  The National Pharmaceutical Council (NPC) today ... policy research organization as its newest member.  ... vice president and chief scientific officer, Mallinckrodt Pharmaceuticals, ... NPC Board of Directors. ... joined us in support of our efforts to ...
(Date:6/23/2016)... , June 23, 2016  Delcath Systems, Inc. (NASDAQ: ... device company focused on treatment of primary and metastatic ... European patient education - www.againsttheodds.eu - has ... Digital Health Awards. The website ... European patients and their families who are coping with ...
Breaking Medicine Technology: